BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trickey A, Hiebert L, Perfect C, Thomas C, El Kaim JL, Vickerman P, Schȕtte C, Hecht R. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planning. Liver Int 2020;40:286-97. [PMID: 31454466 DOI: 10.1111/liv.14232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, Scott N, Chhatwal J, Ball A. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income. Value Health 2020;23:1552-60. [PMID: 33248510 DOI: 10.1016/j.jval.2020.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yunihastuti E, Hariyanto R, Sulaiman AS, Harimurti K. Hepatitis C continuum of care: Experience of integrative hepatitis C treatment within a human immunodeficiency virus clinic in Indonesia. PLoS One 2021;16:e0256164. [PMID: 34383853 DOI: 10.1371/journal.pone.0256164] [Reference Citation Analysis]
3 Artenie A, Luhmann N, Lim AG, Fraser H, Ward Z, Stone J, Macgregor L, Walker JG, Trickey A, Marquez LK, Abu-raddad LJ, Ayoub HH, Walsh N, Hickman M, Martin NK, Easterbrook P, Vickerman P. Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(21)00311-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yunihastuti E, Wicaksana B, Wiraguna A, Hidayah AJ, Amelia F, Natali V, Widhani A, Sulaiman AS, Kurniawan J. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients. BMC Infect Dis 2020;20:372. [PMID: 32450844 DOI: 10.1186/s12879-020-05069-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Walker JG, Mafirakureva N, Iwamoto M, Campbell L, Kim CS, Hastings RA, Doussett JP, Le Paih M, Balkan S, Marquardt T, Maman D, Loarec A, Coast J, Vickerman P. Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia. Liver Int 2020;40:2356-66. [PMID: 32475010 DOI: 10.1111/liv.14550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Boeke CE, Adesigbin C, Agwuocha C, Anartati A, Aung HT, Aung KS, Grover GS, Ngo D, Okamoto E, Ngwije A, Nsanzimana S, Sindhwani S, Singh G, Sun LP, Kinh NV, Waworuntu W, McClure C. Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries: the road to elimination. BMJ Glob Health. 2020;5. [PMID: 33328200 DOI: 10.1136/bmjgh-2020-003767] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]